{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:29:49Z","timestamp":1760452189621},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder related to a deficiency in the enzyme iduronate-2-sulfatase (IDS). Clinical trials of enzyme replacement therapy are in progress, but effective treatment will require screening assays to enable early detection and diagnosis of MPS II. Our study evaluated the diagnostic accuracy of IDS protein and enzyme activity measurements in dried blood spots and plasma.<\/jats:p>\n               <jats:p>Methods: We collected dried-blood-spot and plasma samples from unaffected control individuals and from MPS II patients. We measured IDS protein concentration with a 2-step time-delayed dissociation-enhanced lanthanide fluorescence immunoassay. To measure enzyme activity, we immobilized anti-IDS antibody on microtiter plates to capture the enzyme and measured its activity with the fluorogenic substrate 4-methylumbelliferyl sulfate.<\/jats:p>\n               <jats:p>Results: Dried-blood-spot samples from MPS II patients showed an almost total absence of IDS activity (0\u20130.075 \u03bcmol \u00b7 h\u22121 \u00b7 L\u22121) compared with control blood spots (0.5\u20134.7 \u03bcmol \u00b7 h\u22121 \u00b7 L\u22121) and control plasma (0.17\u20138.1 \u03bcmol \u00b7 h\u22121 \u00b7 L\u22121). A dried-blood-spot sample from only 1 of 12 MPS II patients had detectable concentrations of IDS protein (24.8 \u03bcg\/L), but no IDS protein was detected in plasma from MPS II patients. Ranges for IDS protein in control samples were 25.8\u2013153 \u03bcg\/L for blood spots and 22.8\u2013349.4 \u03bcg\/L for plasma.<\/jats:p>\n               <jats:p>Conclusion: Measurement of the IDS protein concentration and enzyme activity (as measured by a simple fluorogenic assay with an immune capture technique) enables identification of the majority of MPS II patient samples from both dried blood spots and plasma samples.<\/jats:p>","DOI":"10.1373\/clinchem.2005.061838","type":"journal-article","created":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T20:59:09Z","timestamp":1140728349000},"page":"643-649","source":"Crossref","is-referenced-by-count":24,"title":["Detection of Mucopolysaccharidosis Type II by Measurement of Iduronate-2-Sulfatase in Dried Blood Spots and Plasma Samples"],"prefix":"10.1093","volume":"52","author":[{"given":"Caroline J","family":"Dean","sequence":"first","affiliation":[{"name":"Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children, Youth and Women\u2019s Health Service, North Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle R","family":"Bockmann","sequence":"first","affiliation":[{"name":"Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children, Youth and Women\u2019s Health Service, North Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J","family":"Hopwood","sequence":"first","affiliation":[{"name":"Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children, Youth and Women\u2019s Health Service, North Adelaide, South Australia, Australia"},{"name":"Department of Paediatrics, University of Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug A","family":"Brooks","sequence":"first","affiliation":[{"name":"Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children, Youth and Women\u2019s Health Service, North Adelaide, South Australia, Australia"},{"name":"Department of Paediatrics, University of Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"Meikle","sequence":"first","affiliation":[{"name":"Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children, Youth and Women\u2019s Health Service, North Adelaide, South Australia, Australia"},{"name":"Department of Paediatrics, University of Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,4,1]]},"reference":[{"key":"2020022801312058600_R1","unstructured":"Neufeld EF, Muenzer J. The mucopolysaccharidoses. Scriver CR Beaudet AL Sly WS Valle D eds. The metabolic bases of inherited diseases, 8th ed2001:3421-3452 McGraw-Hill New York. ."},{"key":"2020022801312058600_R2","doi-asserted-by":"crossref","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat2003;21:577-581.","DOI":"10.1002\/humu.10212"},{"key":"2020022801312058600_R3","doi-asserted-by":"crossref","unstructured":"Villani GR, Balzano N, Grosso M, Salvatore F, Izzo P, Di Natale P. Mucopolysaccharidosis type II: identification of six novel mutations in Italian patients. Hum Mutat1997;10:71-75.","DOI":"10.1002\/(SICI)1098-1004(1997)10:1<71::AID-HUMU10>3.0.CO;2-X"},{"key":"2020022801312058600_R4","doi-asserted-by":"crossref","unstructured":"Froissart R, Moreira da Silva I, Guffon N, Bozon D, Maire I. Mucopolysaccharidosis type II\u2014genotype\/phenotype aspects. Acta Paediatr Suppl2002;91:82-87.","DOI":"10.1111\/j.1651-2227.2002.tb03116.x"},{"key":"2020022801312058600_R5","doi-asserted-by":"crossref","unstructured":"Parkinson EJ, Muller V, Hopwood JJ, Brooks DA. Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients. Mol Genet Metab2004;81:58-64.","DOI":"10.1016\/j.ymgme.2003.11.002"},{"key":"2020022801312058600_R6","doi-asserted-by":"crossref","unstructured":"Vellodi A, Young E, Cooper A, Lidchi V, Winchester B, Wraith JE. Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis1999;22:638-648.","DOI":"10.1023\/A:1005525931994"},{"key":"2020022801312058600_R7","doi-asserted-by":"crossref","unstructured":"Wenstrup RJ, Bailey L, Grabowski GA, Moskovitz J, Oestreich AE, Wu W, et al. Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy. Blood2004;104:1253-1257.","DOI":"10.1182\/blood-2003-11-3854"},{"key":"2020022801312058600_R8","doi-asserted-by":"crossref","unstructured":"Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, et al. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet2004;75:65-74.","DOI":"10.1086\/422366"},{"key":"2020022801312058600_R9","doi-asserted-by":"crossref","unstructured":"Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-l-iduronidase (laronidase). J Pediatr2004;144:581-588.","DOI":"10.1016\/j.jpeds.2004.01.046"},{"key":"2020022801312058600_R10","doi-asserted-by":"crossref","unstructured":"Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, Miranda MC, et al. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics2005;115:e681-e689.","DOI":"10.1542\/peds.2004-1023"},{"key":"2020022801312058600_R11","doi-asserted-by":"crossref","unstructured":"Muenzer J, Lamsa JC, Garcia A, Dacosta J, Garcia J, Treco DA. Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. Acta Paediatr Suppl2002;91:98-99.","DOI":"10.1111\/j.1651-2227.2002.tb03118.x"},{"key":"2020022801312058600_R12","doi-asserted-by":"crossref","unstructured":"Fuller M, Brooks DA, Evangelista M, Hein LK, Hopwood JJ, Meikle PJ. Prediction of neuropathology in mucopolysaccharidosis I patients. Mol Genet Metab2005;84:18-24.","DOI":"10.1016\/j.ymgme.2004.09.004"},{"key":"2020022801312058600_R13","doi-asserted-by":"crossref","unstructured":"Hein LK, Meikle PJ, Dean CJ, Bockmann MR, Auclair D, Hopwood JJ, et al. Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots. Clin Chim Acta2005;353:67-74.","DOI":"10.1016\/j.cccn.2004.10.009"},{"key":"2020022801312058600_R14","doi-asserted-by":"crossref","unstructured":"Fuller M, Lovejoy M, Brooks DA, Harkin ML, Hopwood JJ, Meikle PJ. Immunoquantification of \u03b1-galactosidase: evaluation for the diagnosis of Fabry disease. Clin Chem2004;50:1979-1985.","DOI":"10.1373\/clinchem.2004.037937"},{"key":"2020022801312058600_R15","doi-asserted-by":"crossref","unstructured":"Umapathysivam K, Hopwood JJ, Meikle PJ. Determination of acid \u03b1-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem2001;47:1378-1383.","DOI":"10.1093\/clinchem\/47.8.1378"},{"key":"2020022801312058600_R16","doi-asserted-by":"crossref","unstructured":"Keulemans JL, Sinigerska I, Garritsen VH, Huijmans JG, Voznyi YV, van Diggelen OP, et al. Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay. Prenat Diagn2002;22:1016-1021.","DOI":"10.1002\/pd.457"},{"key":"2020022801312058600_R17","doi-asserted-by":"crossref","unstructured":"Bielicki J, Freeman C, Clements PR, Hopwood JJ. Human liver iduronate-2-sulphatase. Purification, characterization, and catalytic properties. Biochem J1990;271:75-86.","DOI":"10.1042\/bj2710075"},{"key":"2020022801312058600_R18","doi-asserted-by":"crossref","unstructured":"Voznyi YV, Keulemans JL, van Diggelen OP. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis2001;24:675-680.","DOI":"10.1023\/A:1012763026526"},{"key":"2020022801312058600_R19","doi-asserted-by":"crossref","unstructured":"Chamoles NA, Blanco MB, Gaggioli D, Casentini C. Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper. Clin Chem2001;47:2098-2102.","DOI":"10.1093\/clinchem\/47.12.2098"},{"key":"2020022801312058600_R20","doi-asserted-by":"crossref","unstructured":"Bielicki J, Hopwood JJ, Wilson PJ, Anson DS. Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem J1993;289(Pt 1):241-246.","DOI":"10.1042\/bj2890241"},{"key":"2020022801312058600_R21","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Brooks DA, Ravenscroft EM, Yan M, Williams RE, Jaunzems AE, et al. Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin Chem1997;43:1325-1335.","DOI":"10.1093\/clinchem\/43.8.1325"},{"key":"2020022801312058600_R22","doi-asserted-by":"crossref","unstructured":"Anson DS, Taylor JA, Bielicki J, Harper GS, Peters C, Gibson GJ, et al. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J1992;284(Pt 3):789-794.","DOI":"10.1042\/bj2840789"},{"key":"2020022801312058600_R23","doi-asserted-by":"crossref","unstructured":"Hopwood JJ. \u03b1-l-Iduronidase, \u03b2-d-glucuronidase, and 2-sulfo-l-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin. Carbohydr Res1979;69:203-216.","DOI":"10.1016\/S0008-6215(00)85765-1"},{"key":"2020022801312058600_R24","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Fietz MJ, Hopwood JJ. Diagnosis of lysosomal storage disorders: current techniques and future directions. Expert Rev Mol Diagn2004;4:677-691.","DOI":"10.1586\/14737159.4.5.677"},{"key":"2020022801312058600_R25","doi-asserted-by":"crossref","unstructured":"Villani GR, Daniele A, Balzano N, Di Natale P. Expression of five iduronate-2-sulfatase site-directed mutations. Biochim Biophys Acta2000;1501:71-80.","DOI":"10.1016\/S0925-4439(00)00006-5"},{"key":"2020022801312058600_R26","doi-asserted-by":"crossref","unstructured":"Bonuccelli G, Di Natale P, Corsolini F, Villani G, Regis S, Filocamo M. The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II. Biochim Biophys Acta2001;1537:233-238.","DOI":"10.1016\/S0925-4439(01)00075-8"},{"key":"2020022801312058600_R27","unstructured":"Hopwood JJ, Ballabio A. Multiple sulfatase deficiency and the nature of the sulfatase family. Scriver CR Beaudet AL Sly WS Valle D eds. The metabolic bases of inherited diseases, 8th ed2001:3725-3732 McGraw-Hill New York. ."},{"key":"2020022801312058600_R28","doi-asserted-by":"crossref","unstructured":"Hanson SR, Best MD, Wong CH. Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl2004;43:5736-5763.","DOI":"10.1002\/anie.200300632"},{"key":"2020022801312058600_R29","doi-asserted-by":"crossref","unstructured":"Butler JE. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods2000;22:4-23.","DOI":"10.1006\/meth.2000.1031"},{"key":"2020022801312058600_R30","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA1999;281:249-254.","DOI":"10.1001\/jama.281.3.249"},{"key":"2020022801312058600_R31","doi-asserted-by":"crossref","unstructured":"Hadd AG, Brown JT, Andruss BF, Ye F, WalkerPeach CR. Adoption of array technologies into the clinical laboratory. Expert Rev Mol Diagn2005;5:409-420.","DOI":"10.1586\/14737159.5.3.409"},{"key":"2020022801312058600_R32","doi-asserted-by":"crossref","unstructured":"Karageorgos LE, Isaac EL, Brooks DA, Ravenscroft EM, Davey R, Hopwood JJ, et al. Lysosomal biogenesis in lysosomal storage disorders. Exp Cell Res1997;234:85-97.","DOI":"10.1006\/excr.1997.3581"},{"key":"2020022801312058600_R33","doi-asserted-by":"crossref","unstructured":"Hua CT, Hopwood JJ, Carlsson SR, Harris RJ, Meikle PJ. Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders. Clin Chem1998;44:2094-2102.","DOI":"10.1093\/clinchem\/44.10.2094"},{"key":"2020022801312058600_R34","doi-asserted-by":"crossref","unstructured":"Chang MH, Bindloss CA, Grabowski GA, Qi X, Winchester B, Hopwood JJ, et al. Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders. Clin Chem2000;46:167-174.","DOI":"10.1093\/clinchem\/46.2.167"},{"key":"2020022801312058600_R35","unstructured":"Meikle PJ, Dean CJ, Grasby D, Bockmann MR, Whittle AM, Lang DL, et al. Newborn screening for lysosomal storage disorders: evaluation of protein profiling [Abstract]. J Inherit Metab Dis2005;28(Suppl 1):14."}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/4\/643\/32687122\/clinchem0643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/4\/643\/32687122\/clinchem0643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T01:32:41Z","timestamp":1582853561000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/52\/4\/643\/5627054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,4,1]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.061838","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,4,1]]},"published":{"date-parts":[[2006,4,1]]}}}